Pfizer recalls millions of Nurtec ODT migraine drug packs over child poisoning risk and packaging flaw.

TL;DR
Pfizer is recalling over four million packages of Nurtec ODT prescription migraine medication due to a risk of poisoning to children as the packaging does not meet child-resistant packaging safety requirements. The medication was distributed at pharmacies nationwide from Dec. 2021 through March 2023. Consumers can obtain a free child-resistant pouch to store the product and pharmacists will place the blister packages into vials with child-resistant lids when filling patient prescriptions. No incidents have been reported in connection with the issue. Pfizer is working to create new packaging for the medication to comply with child-resistant packaging requirements.
- Pfizer recalls Nurtec ODT migraine prescription drug packs due to a risk of child poisoning NBC News
- Pfizer and Biohaven recall 4.2M Nurtec units on packaging flaw FiercePharma
- Pfizer recalls millions of migraine prescription drug packs due to a risk of child poisoning AOL
- Nurtec ODT recall: Pfizer to develop new packaging after product didn't meet child-resistant requirements Fox Business
- Pfizer recalls Nurtec ODT migraine therapy over packaging defect (NYSE:PFE) Seeking Alpha
Want the full story? Read the original reporting
Read on NBC News